| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 12/26/2007 | EP1869069A2 Means and methods for producing polymers comprising peptide in a side chain |
| 12/26/2007 | EP1869068A1 Antibacterial amide-macrocycles v |
| 12/26/2007 | EP1868630A2 Semi-synthetic desmethyl-vancomycin-based glycopeptides with antibiotic activity |
| 12/26/2007 | EP1409518B1 Use of fragments of oxytocin for the preparation of a pharmaceutical composition in order to create eustasis |
| 12/26/2007 | EP1116029B1 Apoptosis marker antibodies and methods of use |
| 12/26/2007 | CN101092455A Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 12/26/2007 | CN101092451A Solid phase synthesis method for PT 141 and MT II |
| 12/26/2007 | CN101092450A Heparinase polypeptide epitope combined to molecules in human MIIC ¿CI category |
| 12/26/2007 | CN100357448C Production method for iturin A and its homologues |
| 12/26/2007 | CN100357324C Effectors of innate immunity |
| 12/26/2007 | CN100356981C Ligand oligopeptide specific combining human epidermal growth factor receptor EGFR |
| 12/25/2007 | US7312304 Somatostatin agonists |
| 12/25/2007 | US7312302 Compositions for the detection of enzyme activity in biological samples and methods of use thereof |
| 12/25/2007 | US7312192 For treating diseases including diabetes |
| 12/25/2007 | US7312190 Pharmaceutical compositions of apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 12/25/2007 | US7312188 Alzheimer's disease; for promoting secretion of amyloid precursor protein-alpha (sAPP) |
| 12/21/2007 | WO2007146331A1 Tannate salt form of polypeptide mixtures, their preparation and use |
| 12/21/2007 | WO2007145589A1 Peptides that are capable of binding to amyloid-beta peptide. |
| 12/21/2007 | WO2007144554A2 Gnrh (gonadotropin-releasing hormone) peptide variants |
| 12/21/2007 | WO2007144411A1 New supported oxidation reactants, process for their preparation and uses thereof |
| 12/21/2007 | WO2007144200A1 Process for the covalent coupling of two molecules by means of a diels-alder reaction with inverse electron requirement |
| 12/21/2007 | WO2007143917A1 T cell epitope peptides of 6b11 ovarian cancer anti-idiotypic antibody |
| 12/21/2007 | WO2007124750A3 Methods for isolation and analysis of sialylated and phosphorylated peptides |
| 12/21/2007 | WO2007064997A3 Compounds and methods for inhibiting apoptosis |
| 12/21/2007 | WO2002072068A3 Lipids, lipid compositions, liposomes, and lipoplexes |
| 12/21/2007 | CA2655090A1 New supported oxidation reactants, process for their preparation and uses thereof |
| 12/21/2007 | CA2654289A1 Peptides that mimic non-human cross-reactive protective epitopes of the group b meningococcal capsular polysaccharide |
| 12/20/2007 | US20070293657 Complexes and methods of forming complexes of ribonucleic acids and peptides |
| 12/20/2007 | US20070293434 Binding polypeptides and methods based thereon |
| 12/20/2007 | US20070293424 Antitumoral and Antiviral Peptides |
| 12/20/2007 | US20070293422 Beta-Amyloid Inhibitors and Use Thereof |
| 12/20/2007 | US20070293418 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive and nervous system disorders |
| 12/20/2007 | US20070292933 Inhibitors of serine proteases, particular HCV NS3-NS4A protease |
| 12/20/2007 | US20070292907 Compositions and method for regulating ubiquitin-specific processing proteases |
| 12/20/2007 | US20070292447 Peptide Minotopes of Mycobacterial Mannosylated Lipoglycans and Uses Thereof |
| 12/20/2007 | US20070292347 Peptides Associated with Hla-Dr Mhc Clas II Molecules Involved in Autoimmune Diseases |
| 12/20/2007 | US20070290173 Highly homogenoeous molecular markers for electrophoresis |
| 12/19/2007 | EP1867638A1 Procedure for the Conection of two Molecules via Diels-Alder Reactions with Inverse Electron Demand |
| 12/19/2007 | EP1866415A2 A cysteine-containing peptide tag for site-specific conjugation of proteins |
| 12/19/2007 | EP1866328A1 Peptides which increase collagen or hyaluronic acid production |
| 12/19/2007 | EP1095061B1 Peptides based on the sequence of human lactoferrin and their use |
| 12/19/2007 | CN100355776C Novel alpha-melanocyte stimulating hormone analogue and use thereof |
| 12/19/2007 | CN100355775C Polypeptide of ascidicea and preparation thereof |
| 12/18/2007 | US7309759 Indolicidin peptide analogues containing at least two basic amino acids; bactericide |
| 12/18/2007 | US7309694 Gene therapy; cytokine complex; anticancer agent |
| 12/18/2007 | US7309690 Parenterally or nasally administering zinc-free immune-system-inactive thymulin peptide analogue: Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asp; migraine, sciatica, neuropathy and inflammatory pain |
| 12/18/2007 | US7309595 Comprises protease for use in generating proline rich protein hydrolysate for use in food and drink to decrease allergenicity, facilitate gastrointestinal uptake and to stabilize proteins in acid products against precipitation during prolonged storage |
| 12/18/2007 | CA2249390C Peptides recognized by melanoma-specific a1-, a2- and a3-restricted cytotoxic lymphocytes, and uses therefor |
| 12/18/2007 | CA2179562C Peptide useful in the separation and purification of immunoglobulins |
| 12/13/2007 | WO2007142611A1 Method of polymyxin b recovery from fermentation broth |
| 12/13/2007 | WO2007140953A1 Peptide associated with rheumatic fever (parf) and its use as a diagnostic marker |
| 12/13/2007 | WO2007140534A1 Vegf-a cross-reactive anti- vegf-b antibodies as antagonists of vegf-a and vegf-b signalling |
| 12/13/2007 | WO2007092360A3 Diagnostics and methods for removal and detection of interferents |
| 12/13/2007 | WO2006076255A3 Method of treating or preventing microbial eye infection |
| 12/13/2007 | US20070287671 Compositions and Methods for Promoting Myocardial and Peripheral Angiogenesis |
| 12/13/2007 | US20070287670 Human glucagon-like peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 12/13/2007 | US20070287665 Urotensin-II agonists and antagonists |
| 12/13/2007 | US20070287662 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 12/13/2007 | US20070286935 Bioactive Compositions, Natural Methods of Producing Them and Computational Methods for Designing Natural Production Processes |
| 12/12/2007 | EP1864996A1 Peptide associated with rheumatic fever (PARF) and its use as a diagnostic marker. |
| 12/12/2007 | EP1864995A1 Beta-lactamic rgd cyclopeptides containing gamma turns |
| 12/12/2007 | EP1864675A1 Orally administered peptides to ameliorate atherosclerosis |
| 12/12/2007 | EP1863849A2 Rodent pest control |
| 12/12/2007 | EP1863531A1 Improvements in or relating to treatment and prevention of viral infections |
| 12/12/2007 | EP1863525A2 Polypeptides |
| 12/12/2007 | EP1735335A4 Cell-killing peptide |
| 12/12/2007 | EP1261621A4 Phosphorylation assays |
| 12/12/2007 | EP0888377B1 MURINE alpha(1,3)-FUCOSYLTRANSFERASE (Fuc-TVII) |
| 12/12/2007 | CN101085810A Heptapeptide prepared from thymopentin and pidotimod, and synthetic method |
| 12/12/2007 | CN101085809A Batifeiban and synthetic and preparing technique for analogue thereof |
| 12/12/2007 | CN100354628C Epitopes formed by non-covalent association of conjugates |
| 12/12/2007 | CN100354305C Mage-A1 peptides presented by HLA class II molecules |
| 12/11/2007 | US7307063 Melanocortin metallopeptides for treatment of sexual dysfunction |
| 12/11/2007 | US7307058 Multimeric Apo A-I agonist compounds |
| 12/11/2007 | US7306784 Complexing; drug delivery; in situ imaging |
| 12/11/2007 | CA2259141C Treatment and diagnosis of infections of gram positive cocci |
| 12/11/2007 | CA2221865C Bradykinin analogs as selective thrombin inhibitors |
| 12/06/2007 | WO2007138999A1 Glycopeptide antibiotic derivative |
| 12/06/2007 | WO2007138171A1 Bioactive cyclic peptide |
| 12/06/2007 | WO2007137456A1 A peptide for preventing or treating liver damage and its derivant and the use |
| 12/06/2007 | WO2007112352A3 Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders |
| 12/06/2007 | WO2007107680A3 Molecular imprintings for recognition in aqueous media, methods for preparing same and uses thereof |
| 12/06/2007 | WO2007002534A3 Thrombospondin-1 derived peptides and treatment methods |
| 12/06/2007 | WO2006086653A3 Methods and compositions for the treatment of gastrointestinal disorders |
| 12/06/2007 | US20070281895 Molecular Marker |
| 12/06/2007 | US20070281302 Peptide ligands for Bacillus anthracis spore detection |
| 12/06/2007 | US20070280962 HBV core antigen particles with multiple immunogenic components attached via peptid ligands |
| 12/06/2007 | US20070280956 Novel hepatitis C virus peptides and uses thereof |
| 12/06/2007 | US20070280939 Prostatic Acid Phosphatase Antigens |
| 12/06/2007 | US20070280938 Peptides Derived from Natural Cytotoxicity Receptors and Methods of Use Thereof |
| 12/06/2007 | DE102006025146A1 Peptide that modulates proteasome activity, e.g. for disease treatment, comprises a human protein sequence |
| 12/06/2007 | CA2652506A1 Glycopeptide antibiotic derivative |
| 12/05/2007 | EP1862471A2 Pharmacologically active antiviral peptides and methods of their use |
| 12/05/2007 | EP1862470A1 Element retained in blood showing degradability selectively in tumor tissue |
| 12/05/2007 | EP1862174A1 Inhibitor for insulin polymer formation |
| 12/05/2007 | EP1861413A1 Ionic liquid supported synthesis |
| 12/05/2007 | EP1635692A4 Monitoring immunologic, hematologic and inflammatory diseases |
| 12/05/2007 | EP1537421B1 A method for the identification of drug targets |
| 12/05/2007 | EP0975374B1 Radiometal-binding peptide analogues |
| 12/05/2007 | CN101084240A MyD88 homodimerization inhibitors |